Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways

pengarang

Valentina Leo

Carmela Nacci

Angela Stefanachi

Modesto de Candia

Francesco Leonetti

monica montagnani

Saverio Cellamare

Angelo Carotti

diterbitkan dalam: Journal of Pharmacy and Pharmacology

tanggal publikasi: 2015-06-16

subyek utama: Faktor nekrosis tumor-alfa

Cites articles 51

Date

Judul

Pengarang

2014-06-12

Requirement of JNK1 for endothelial cell injury in atherogenesis

Christina M Warboys, Sheila E. Francis, Paul Evans
2012-02-01

Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies
2011-11-01

c-Jun, at the crossroad of the signaling network
2011-02-03

COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.
2011-12-23

Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein

Mauro Niso, Angela Stefanachi, Francesco Leonetti, Orazio Nicolotti, Saverio Cellamare, Roberto Perrone, Angelo Carotti
2011-01-24

Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia.

Joseph Cheriyan
2011-07-06

Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies

Véronique Baud, Françoise Cormier, Ivan Bieche, Sophie Vacher
2010-04-01

Small molecule JNK (c-Jun N-terminal kinase) inhibitors.
2010-01-07

c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis

Andrew R. Clark, Kim Van der Heiden, Adam Platt, Paul Evans
2009-01-01

JWA sensitizes P-glycoprotein-mediated drug-resistant choriocarcinoma cells to etoposide via JNK and mitochondrial-associated signal pathway
2009-09-18

PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.
2009-05-08

Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38

Derek Duckett, Philip LoGrasso, Jeff E Habel, Theodore M Kamenecka, Youseung Shin, Xinyi Song
2009-02-26

Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors
2009-04-01

Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase
2009-08-01

Signal integration by JNK and p38 MAPK pathways in cancer development

Erwin F. Wagner
2009-03-01

p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus
2008-10-01

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
2008-07-24

c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia
2008-10-15

Identification of a new JNK inhibitor targeting the JNK-JIP interaction site

Michael Karin
2008-10-27

c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.

Markus Bachschmid, Francesco Cosentino, Giovanni G. Camici, Thomas Lüscher, Jan Borén
2007-03-06

Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways
2007-06-01

Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN.

Igor Vivanco, Stephen P. Finn, Nicolaos Palaskas, Massimo Loda, Gad Getz, Todd Golub
2007-12-01

The selectivity of protein kinase inhibitors: a further update

Simon J. Arthur, Dario Alessi
2006-01-01

Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase

Jun Zhou
2006-12-15

N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3

Francis Atkinson
2006-01-18

Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles
2006-11-01

The JIP family of MAPK scaffold proteins

Alan J Whitmarsh
2005-04-01

From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance

Michael Karin
2005-07-01

Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase

Montserrat Camps
2004-11-01

Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.

Romeo Ricci, Martin Hersberger, Erwin F. Wagner, Thomas Lüscher, Urs Eriksson, Myron I. Cybulsky, Kathryn J. Moore, Jan Borén, Burkhard Becher, Grzegorz Sumara, Alexander Akhmedov, Izabela Rozenberg, Michael O Kurrer
2004-05-13

Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125.

Young Ho Jeon, Chul-Hak Yang
2004-09-01

Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation

Erwin F. Wagner, Michael Karin, Konrad Hochedlinger

Artikel - wd:Q38995223

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut